A detailed history of First Affirmative Financial Network transactions in Cellectis S.A. stock. As of the latest transaction made, First Affirmative Financial Network holds 21,094 shares of CLLS stock, worth $39,445. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,094
Holding current value
$39,445
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$1.9 - $2.4 $40,078 - $50,625
21,094 New
21,094 $44,000

Others Institutions Holding CLLS

About Cellectis S.A.


  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $85.1M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track First Affirmative Financial Network Portfolio

Follow First Affirmative Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on First Affirmative Financial Network with notifications on news.